Addiction treatment in Texas

Texas presents a specific set of structural conditions — 733 licensed facilities, the Southwest geographic context, and state-level policy choices around Medicaid and treatment regulation — that together determine access. Patient outcomes in the state reflect those conditions more than they reflect the clinical merits of individual programs.

The Medicaid question

Texas has not expanded Medicaid under the Affordable Care Act. Medicaid expansion status is the single most consequential state-level policy lever for addiction-treatment access. Typically falls into the eligibility gap — income too high for traditional Medicaid, too low to qualify for substantial Marketplace subsidies. This affects not only direct patient coverage but provider-network composition, since facilities that accept Medicaid tend to correlate with those that operate within generally accepted clinical standards (ASAM-aligned, MAT-inclusive).

The overdose-mortality context

Texas records 16.0 drug-overdose deaths per 100,000 residents annually (CDC, 2023 final). The state-level variation — largest Medicaid-eligibility-gap population in the country — requires an interpretive framework that distinguishes rural-urban access gaps, tribal-nation jurisdictions where applicable, and concentrated high-mortality census tracts. Aggregate state-level numbers obscure those distinctions.

How access actually works in Texas

Evaluating specific Texas facilities requires two-document review: (1) state licensing status and inspection history, available through the state behavioral-health regulator; (2) voluntary accreditation through CARF or Joint Commission, verifiable through the respective organizations' provider-search tools. Neither is a proxy for clinical quality, but absence of both is a risk signal.

What to do next

For Texas residents, the institutional-best-practice workflow is: preliminary screening (DSM-5-based self-assessment), professional assessment (licensed substance-use counselor or addiction-medicine specialist), insurance benefits verification (including medical-necessity criteria disclosure), facility selection (ASAM-aligned, MAT-inclusive, accredited), admission, concurrent-review documentation coordination. Skipping the benefits-verification step is the single most common source of patient financial surprise.